156 related articles for article (PubMed ID: 10647910)
21. Oral pharmacokinetics of baicalin, wogonoside, oroxylin A 7-O-β-d-glucuronide and their aglycones from an aqueous extract of Scutellariae Radix in the rat.
Cai Y; Li S; Li T; Zhou R; Wai AT; Yan R
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():124-133. PubMed ID: 26809374
[TBL] [Abstract][Full Text] [Related]
22. Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.
Brand W; Boersma MG; Bik H; Hoek-van den Hil EF; Vervoort J; Barron D; Meinl W; Glatt H; Williamson G; van Bladeren PJ; Rietjens IM
Drug Metab Dispos; 2010 Apr; 38(4):617-25. PubMed ID: 20056724
[TBL] [Abstract][Full Text] [Related]
23. Effect of chrysin on the formation of N-acetyl-p-benzoquinoneimine, a toxic metabolite of paracetamol in rats and isolated rat hepatocytes.
Pingili RB; Pawar AK; Challa SR
Chem Biol Interact; 2019 Apr; 302():123-134. PubMed ID: 30794797
[TBL] [Abstract][Full Text] [Related]
24. Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids.
De Santi C; Pietrabissa A; Spisni R; Mosca F; Pacifici GM
Xenobiotica; 2000 Sep; 30(9):857-66. PubMed ID: 11055264
[TBL] [Abstract][Full Text] [Related]
25. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells--potential role in carcinogen bioinactivation.
Galijatovic A; Otake Y; Walle UK; Walle T
Pharm Res; 2001 Mar; 18(3):374-9. PubMed ID: 11442279
[TBL] [Abstract][Full Text] [Related]
26. Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes.
Otake Y; Hsieh F; Walle T
Drug Metab Dispos; 2002 May; 30(5):576-81. PubMed ID: 11950790
[TBL] [Abstract][Full Text] [Related]
27. SULT1A3-mediated regiospecific 7-O-sulfation of flavonoids in Caco-2 cells can be explained by the relevant molecular docking studies.
Meng S; Wu B; Singh R; Yin T; Morrow JK; Zhang S; Hu M
Mol Pharm; 2012 Apr; 9(4):862-73. PubMed ID: 22352375
[TBL] [Abstract][Full Text] [Related]
28. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
[TBL] [Abstract][Full Text] [Related]
29. Accumulation and metabolism of the anticancer flavonoid 5,7-dimethoxyflavone compared to its unmethylated analog chrysin in the Atlantic killifish.
Tsuji PA; Winn RN; Walle T
Chem Biol Interact; 2006 Dec; 164(1-2):85-92. PubMed ID: 16999945
[TBL] [Abstract][Full Text] [Related]
30. Protection by chrysin, apigenin, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes.
Huang CS; Lii CK; Lin AH; Yeh YW; Yao HT; Li CC; Wang TS; Chen HW
Arch Toxicol; 2013 Jan; 87(1):167-78. PubMed ID: 22864849
[TBL] [Abstract][Full Text] [Related]
31. In-vitro sulfation of piceatannol by human liver cytosol and recombinant sulfotransferases.
Miksits M; Sulyok M; Schuhmacher R; Szekeres T; Jäger W
J Pharm Pharmacol; 2009 Feb; 61(2):185-91. PubMed ID: 19178765
[TBL] [Abstract][Full Text] [Related]
32. Sulfation of hesperetin, naringenin and apigenin by the human cytosolic sulfotransferases: a comprehensive analysis.
El Daibani AA; Xi Y; Luo L; Mei X; Zhou C; Yasuda S; Liu MC
Nat Prod Res; 2020 Mar; 34(6):797-803. PubMed ID: 30398375
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of apigenin by rat liver phase I and phase ii enzymes and by isolated perfused rat liver.
Gradolatto A; Canivenc-Lavier MC; Basly JP; Siess MH; Teyssier C
Drug Metab Dispos; 2004 Jan; 32(1):58-65. PubMed ID: 14709621
[TBL] [Abstract][Full Text] [Related]
34. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat.
Breinholt V; Lauridsen ST; Dragsted LO
Xenobiotica; 1999 Dec; 29(12):1227-40. PubMed ID: 10647909
[TBL] [Abstract][Full Text] [Related]
36. CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells.
Androutsopoulos VP; Ruparelia K; Arroo RR; Tsatsakis AM; Spandidos DA
Toxicology; 2009 Oct; 264(3):162-70. PubMed ID: 19666078
[TBL] [Abstract][Full Text] [Related]
37. Evidence for cytochrome P4501A2-mediated protein covalent binding of thiabendazole and for its passive intestinal transport: use of human and rabbit derived cells.
Coulet M; Eeckhoutte C; Larrieu G; Sutra JF; Alvinerie M; Macé K; Pfeifer A; Zucco F; Stammati AL; De Angelis I; Vignoli AL; Galtier P
Chem Biol Interact; 2000 Jul; 127(2):109-24. PubMed ID: 10936227
[TBL] [Abstract][Full Text] [Related]
38. Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2.
Wang X; Morris ME
Drug Metab Dispos; 2007 Feb; 35(2):268-74. PubMed ID: 17093006
[TBL] [Abstract][Full Text] [Related]
39. Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis.
Yamamoto A; Liu MY; Kurogi K; Sakakibara Y; Saeki Y; Suiko M; Liu MC
J Biochem; 2015 Dec; 158(6):497-504. PubMed ID: 26067475
[TBL] [Abstract][Full Text] [Related]
40. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
